WHO guidelines advise against obesity drugs for children under ten
New World Health Organization guidance recommends lifestyle interventions rather than weight-loss medications or surgery for young children with obesity.
FTMQ Health, written by our newsroom0 views

The World Health Organization has issued new global guidelines recommending against prescribing obesity drugs or weight-loss injections to children under 10 years old, the BBC reported. The agency stated that care for this age group must focus on healthy eating and physical activity rather than pharmaceutical interventions or surgery. [1]
According to the BBC, most GLP-1 weight-loss medications, including Mounjaro and Wegovy, are currently licensed only for older children and adolescents. However, some doctors have prescribed these drugs off-label to younger patients, and pharmaceutical companies are conducting trials in children as young as six years old. The World Health Organization stated it does not oppose clinical drug trials. [1]
The BBC reported that the new guidance endorses the use of digital tools to support healthier lifestyles among children. These approved technologies include activity trackers and active online games that encourage physical movement. [1]
In short
- The World Health Organization advises against giving obesity drugs to children under 10 years old.
- Care for young children with obesity should prioritize diet and exercise over medication or surgery.
- Drug companies are currently testing GLP-1 weight-loss injections in children as young as six.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]New global guidelines warn against obesity drugs for children under 10BBC Health, 45d ago (the report this story comes from)
Our newsroom writes these reports with the help of software, from the 1 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Health
Earlier reports of ours on the same people and subjects.
- Structured support may limit weight regain after stopping GLP-1 drugsTop Stories, 45d ago
- MPs call for NHS weight management overhaul following Mounjaro rolloutHealth Care, 29d ago
- Experimental weight loss drug retatrutide reduces knee pain in trialsMedical Science, 12d ago
- Government review urges maximum waiting times for youth mental health careHealth Care, 3d ago
More in Top Stories
- United Therapeutics performs first UThymoKidney transplant in EXTEND trial16h ago
- Princeton neuroscience researcher detained by ICE following conference16h ago
- FDA rejects Capricor Therapeutics Duchenne muscular dystrophy cell therapy16h ago
- Northern Ireland ambulance service misses two-hour target over 2,000 times1d ago
- Senior surgeon calls for police investigation into Scottish hospital patient deaths1d ago
- Malaria antibody prevents infection in infants but interferes with vaccine1d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.